‡ Lipper is an industry research firm whose rankings are based on total return performance, vary over time, and do not reflect the effects of sales charges. Past performance is not indicative of future results.
Putnam Advisor
Putnam Sustainable Future Subaccount
The subaccount seeks long-term capital appreciation.
Fund description
The subaccount employs a value strategy to identify undervalued, high-quality companies among the market's mid-cap offerings. The subaccount's managers seek stocks they believe have been under-estimated by the market. They target profitable, established companies of two kinds: smaller companies that have grown to midsize, and larger companies that have fallen out of favor temporarily but are expected to recover.
Sales story
Investing in sustainable solutionsImpact companies The subaccount invests in companies we believe have strong fundamentals that offer potential solutions to key sustainability challenges. Active research process A framework grounded in fundamental research and focused on impact-oriented sustainability solutions drives investment decisions. Experienced teamAn experienced, dedicated sustainable investing team is integrated with Putnam's equity research group.
Management team
- Katherine Collins, CFA, MTS (Investing since 1990)
- Stephanie Dobson (Investing since 2011)
Daily pricing as of 03/22/23
| with optional enhanced death benefits | ||
|---|---|---|
| Unit Value | $42.605594 | $41.339657 |
| Unit Value Change | -0.791176 | -0.767845 |
Lipper ranking ‡ as of 02/28/23
Category: Multi-Cap Growth Funds
| Percentile ranking | Rank/Funds in category | |
|---|---|---|
| 10 yrs. | 89% | 55/61 |
| 1 yr. | 65% | 45/69 |
| 3 yrs. | 70% | 46/65 |
| 5 yrs. | 70% | 46/65 |
Quick facts as of 02/28/23
| Fiscal Year End | December |
| Asset Class | Putnam Advisor |
| Subaccount Status | Open to new investors |
| Number of issues | 60 |
| Turnover (fiscal year end) | 64% |
| Net Assets | $26M |
| Inception Date | 05/01/03 |
Performance
Performance as of 12/31/22
| Annualized Performance | Last Quarter | Year to Date |
1 yr. | 3 yrs. | 5 yrs. | 10 yrs. | Life of subaccount |
|---|---|---|---|---|---|---|---|
| Restated performance | |||||||
| Unit Value | 1.63% | -34.85% | -34.85% | 0.94% | 4.39% | 8.17% | 7.49% |
| Standardized | -7.22% | -41.15% | -41.15% | -3.09% | 1.19% | 6.28% | 5.98% |
| With optional enhanced death benefit | |||||||
| Unit Value | 1.59% | -34.95% | -34.95% | 0.79% | 4.23% | 8.00% | 7.33% |
| Standardized | -7.26% | -41.24% | -41.24% | -3.24% | 1.03% | 6.11% | 5.80% |
| Actual performance | |||||||
| Unit Value | 1.63% | -34.85% | -34.85% | 0.94% | 4.39% | 8.17% | 7.49% |
| Standardized | -7.22% | -41.15% | -41.15% | -3.09% | 1.19% | 6.28% | 5.98% |
| With optional enhanced death benefit | |||||||
| Unit Value | -- | -- | -- | -- | -- | -- | -- |
| Standardized | -- | -- | -- | -- | -- | -- | -- |
Annual Performance at NAV
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|---|
| 40.30% | 9.37% | -5.52% | 11.58% | 9.33% | -6.13% | 28.39% | 50.72% | 4.75% | -34.85% |
| With optional enhanced death benefit | |||||||||
| 40.08% | 9.20% | -5.67% | 11.41% | 9.17% | -6.28% | 28.20% | 50.50% | 4.59% | -34.95% |
Restated performance
Monthly as of 02/28/23 |
|
|---|---|
| Unit Value | -1.87% |
| Standardized | -10.48% |
YTD as of 03/22/23 |
|
|---|---|
| Unit Value | 2.93% |
| Standardized | -6.02% |
With optional enhanced death benefit
Monthly as of 02/28/23 |
|
|---|---|
| Unit Value | -1.88% |
| Standardized | -10.49% |
YTD as of 03/22/23 |
|
|---|---|
| Unit Value | 2.89% |
| Standardized | -6.05% |
Unit values and performance information shown apply to the specific annuity product listed, not the underlying Putnam Variable Trust fund. This information should not be used by investors who hold an interest in Putnam Variable Trust funds through a different annuity or other variable product. The unit values and performance of other variable products that offer Putnam Variable Trust funds may be higher or lower due to product charges and expenses or other factors.
Data is historical. Past performance is no guarantee of future results. More recent returns may be less or more than those shown. Investment return and principal value will fluctuate, and you may have a gain or a loss when you sell your units.
Returns shown for the subaccounts for periods before their inception are derived from the historical performance of the underlying fund, adjusted to reflect the mortality, expense risk, and surrender charges applicable to this product and do not factor in the annual $30 contract maintenance fee. Additional riders and options for insurance-related charges will increase expenses and lower returns. Please see the prospectus for details. For a portion of the period, subaccounts may have limited expenses, without which returns would have been lower.
Variable annuities are long-term investments designed for retirement purposes. Putnam Capital Manager products are flexible-premium variable annuities held by Talcott Resolution Life, Inc., Simsbury, CT.
Putnam Everlake variable annuities are flexible-premium deferred variable annuities issued by Everlake Life Insurance Company (Everlake Life); underwritten by Everlake Distributors, L.L.C., both of Northbrook, IL; and sold through registered representatives or bank employees who are licensed insurance agents. Please check for availability in your specific state.
These policies have limitations and are sold by prospectus only. The prospectus contains details on the variable annuity, the subaccounts, contract features, fees, expenses, and other pertinent information.
Investors should carefully consider the investment objectives, risks, charges, and expenses of a fund before investing. For a prospectus containing this and other information for any variable annuity or variable life product that invests in Putnam Variable Trust funds, contact your financial advisor for a contract prospectus and prospectus for the underlying funds. You may also call Talcott Resolution at 1-800-521-0538 or Everlake at 1-800-390-1277. Read the prospectuses carefully before investing.
For the most recent month-end performance, please call Talcott Resolution at 1-800-521-0538 or Everlake at 1-800-390-1277.
Risk Characteristics as of 02/28/23
| Alpha (%) | -3.51 |
| Beta | 0.99 |
| R Squared | 0.96 |
| Standard Deviation (3 yrs.) | 24.84 |
Holdings
| Chipotle Mexican Grill | 3.05% |
| Dexcom | 2.98% |
| Cintas Corp | 2.89% |
| Cadence Design Systems | 2.89% |
| Msci | 2.72% |
| Thermo Fisher Scientific | 2.66% |
| Regeneron Pharmaceuticals | 2.32% |
| Palo Alto Networks | 2.27% |
| Gartner | 2.21% |
| Danaher Corp | 2.11% |
| Top 10 holdings, total: | 26.09% |
| Top 10 holdings as of 02/28/23 | |
|---|---|
| 1: Chipotle Mexican Grill | 3.05% |
| 2: Dexcom | 2.98% |
| 3: Cintas Corp | 2.89% |
| 4: Cadence Design Systems | 2.89% |
| 5: Msci | 2.72% |
| 6: Thermo Fisher Scientific | 2.66% |
| 7: Regeneron Pharmaceuticals | 2.32% |
| 8: Palo Alto Networks | 2.27% |
| 9: Gartner | 2.21% |
| 10: Danaher Corp | 2.11% |
| Holdings represent 26.09% of portfolio | |
| Top 10 holdings as of 01/31/23 | |
|---|---|
| 1: Chipotle Mexican Grill | 3.22% |
| 2: Msci | 2.94% |
| 3: Cintas Corp | 2.80% |
| 4: Dexcom | 2.75% |
| 5: Thermo Fisher Scientific | 2.68% |
| 6: Gartner | 2.42% |
| 7: Danaher Corp | 2.37% |
| 8: Regeneron Pharmaceuticals | 2.22% |
| 9: Bio-Rad Laboratories | 2.07% |
| 10: Casella Waste Systems | 2.03% |
| Holdings represent 25.48% of portfolio | |
| Top 10 holdings as of 12/31/22 | |
|---|---|
| 1: Danaher Corp | 3.39% |
| 2: Dexcom | 3.11% |
| 3: Cintas Corp | 3.05% |
| 4: Msci | 2.97% |
| 5: Chipotle Mexican Grill | 2.91% |
| 6: Thermo Fisher Scientific | 2.77% |
| 7: Gartner | 2.57% |
| 8: Roper Technologies | 2.31% |
| 9: Regeneron Pharmaceuticals | 2.26% |
| 10: Adobe | 2.21% |
| Holdings represent 27.54% of portfolio | |
| Top 10 holdings as of 11/30/22 | |
|---|---|
| 1: Danaher Corp | 3.19% |
| 2: Chipotle Mexican Grill | 3.11% |
| 3: Msci | 2.96% |
| 4: Dexcom | 2.92% |
| 5: Cintas Corp | 2.85% |
| 6: Thermo Fisher Scientific | 2.58% |
| 7: Gartner | 2.45% |
| 8: Nextera Energy | 2.39% |
| 9: Mccormick Md | 2.39% |
| 10: Regeneron Pharmaceuticals | 2.15% |
| Holdings represent 26.99% of portfolio | |
Portfolio Composition as of 02/28/23
| Common stock | 96.84% |
| Cash and net other assets | 3.16% |
Consider these risks before investing: The value of investments in the fund’s portfolio may fall or fail to rise over extended periods of time for a variety of reasons, including general economic, political, or financial market conditions; investor sentiment and market perceptions; government actions; geopolitical events or changes; and factors related to a specific issuer, geography, industry, or sector. These and other factors may lead to increased volatility and reduced liquidity in the fund’s portfolio holdings. Growth stocks may be more susceptible to earnings disappointments, technological obsolescence, falling prices and profits, and the market may not favor growth-style investing. Investments in small and midsize companies increase the risk of greater price fluctuations. International investing involves currency, economic, and political risks. Emerging-market securities have illiquidity and volatility risks. The fund's sustainable and environmental, social, and/or corporate governance (ESG) investment strategy may cause the fund to forego otherwise attractive investment opportunities or may increase or decrease the fund’s exposure to certain types of companies and, therefore, to underperform funds that do not invest with a similar focus. From time to time, the fund may invest a significant portion of its assets in companies in one or more related industries or sectors, which would make the fund more vulnerable to adverse developments affecting those industries or sectors. In evaluating an investment opportunity, we may make investment decisions based on information and data that is incomplete or inaccurate. Due to changes in the products or services of the companies in which the fund invests, the fund may temporarily hold securities that are inconsistent with its sustainable investment criteria. Our investment techniques, analyses, and judgments may not produce the outcome we intend. The investments we select for the fund may not perform as well as other securities that we do not select for the fund. We, or the fund’s other service providers, may experience disruptions or operating errors that could have a negative effect on the fund. You can lose money by investing in the fund. Variable annuities are long-term investments designed for retirement purposes. Withdrawals prior to age 59 1/2 may be subject to a 10% IRS penalty.
Sector weightings as of 02/28/23
| Information technology | 31.36% |
|---|---|
| Health care | 24.09% |
| Industrials | 13.04% |
| Consumer discretionary | 8.16% |
| Financials | 7.15% |
| Materials | 4.75% |
| Communication services | 3.48% |
| Consumer staples | 3.20% |
| Cash and net other assets | 3.16% |
| Other | 1.61% |
0
Expenses
Sales Charges/Fees
| Breakpoint | Sales Charge | Dealer Allowance | CDSC Liab |
|---|---|---|---|
| $0 - $0 | 0.00% | 0.00% | N |
CDSC
| Year | Percent |
|---|---|
| 1 | 7.00% |
| 2 | 7.00% |
| 3 | 6.00% |
| 4 | 5.00% |
| 5 | 4.00% |
| 6 | 3.00% |
| 7 | 2.00% |
| 8+ | 0.00% |